NICOLE MCKENZIE: Open Payments
NPI 1699144071 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,656 in 165 payments from 39 companies in 2025. Trend: 2023 $3,736 · 2024 $3,800 · 2025 $3,656
Food & beverage: $3,571Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $359 |
| AstraZeneca Pharmaceuticals LP | 14 | $339 |
| Rigel Pharmaceuticals, Inc. | 12 | $292 |
| PFIZER INC. | 13 | $202 |
| Novartis Pharmaceuticals Corporation | 10 | $199 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $195 |
| ABBVIE INC. | 11 | $193 |
| SOBI, INC | 6 | $180 |
| Merck Sharp & Dohme LLC | 7 | $148 |
| Geron Corporation | 5 | $126 |
Products named: TAVALISSE, RYBREVANT, ELREXFIO, Nubeqa, KEYTRUDA, Lenvima, RYTELO, REBLOZYL.
Industry payments across CT — which companies pay providers there.
